Effect of Extra Virgin Olive Oil on Women at Risk for Preeclampsia
Official title: Effect of Extra Virgin Olive Oil Addition in the Diet of Women with Higher Risk for Preeclampsia - Interventional Pilot Study
Run by Barzilai Medical Center · NCT06759545 · Data updated 2026-11-12
This study is testing whether drinking extra virgin olive oil every day can help high-risk pregnant women lower their chances of developing preeclampsia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 156 (estimated) |
| Sponsor | Barzilai Medical Center Academic / other |
| Locations | 1 site (Ashkelon, Ashkelon District) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | January 7, 2027 |
| Study ends | January 7, 2028 |
| Registry record updated | February 6, 2025 |
| Trial ID | NCT06759545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18 to 45 with clinical risk factors for preeclampsia, such as previous preeclampsia, chronic hypertension, or obesity.
✕Probably not a fit
Patients who do not have clinical risk factors for preeclampsia or those who refuse participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the potential benefits of Extra Virgin Olive Oil from early harvested olives in reducing the risk of preeclampsia among high-risk pregnant women. The intervention involves a daily intake of 42 ml of this olive oil, which is rich in antioxidants and may improve vascular health and reduce oxidative stress. The primary objective is to evaluate the incidence of preeclampsia and its related markers during pregnancy in a randomized, parallel-assignment dietary trial involving 156 participants aged 18 to 45. The study aims to assess the impact of this dietary intervention on pregnancy outcomes, including gestational diabetes mellitus.
Why it matters
Potential benefit: If successful, this intervention could significantly lower the risk of preeclampsia and improve pregnancy outcomes for high-risk women.
How similar studies have gone: While dietary interventions for preeclampsia risk are being explored, this specific approach using Extra Virgin Olive Oil is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women with clinical risk factors for PE \[previous PE, primigravida, chronic hypertension, chronic renal disease, autoimmune disease (systemic lupus erythematosus, antiphospholipid antibody syndrome), overweight (BMI\>30), obesity (BMI\>35), morbid obesity (BMI\>40), presentational diabetes (type 1 or type 2), multiple pregnancy\]. * gestational ages of 8 to 16 weeks attending Barzilai University Medical Center at Ashkelon (BUMCA). Exclusion Criteria: • Refusing enrollment or participation.
Where it's running
-
Barzilai University Medical Center
Ashkelon, Ashkelon District, Israel Recruiting
Study contacts
- Study coordinator: Yaniv Dr Yaniv S. Ovadia, RD PhD
- Email: yaniv.ovadia@mail.huji.ac.il
- Phone: + 972 8 6745220
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Preeclampsia risk in early pregnancy and long-term heart health in women with type 1 diabetes
We’re testing whether a high estimated risk of preeclampsia in the first trimester is linked to hidden heart and blood vessel changes and future cardiovascular problems in women with type 1 diabetes.
-
Blood protein markers and heart changes in pregnant women with preeclampsia
This study tests whether blood proteins can reveal early heart changes in pregnant women with preeclampsia and uses heart ultrasound to see how the heart changes during pregnancy.
-
Hyperspectral imaging to predict preeclampsia risk
This study will test whether a non-contact camera method called hyperspectral imaging can spot early microcirculation changes and help predict which pregnant people will develop preeclampsia.
-
Examining how aspirin metabolism relates to metabolic dysfunction in pregnant individuals at risk of preeclampsia
This study is trying to see how the way pregnant people process aspirin relates to their metabolic health and the health of their babies, especially for those at risk of preeclampsia.
-
Preeclampsia and normal pregnancy: retinal microcirculation using OCTA
This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.